About Enhancer
| Enhancer ID: | E_02_0122 |
| Species: | mouse |
| Position : | chr11:108808163-108810163   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Cystic kidney disease |
| Pubmed ID: | 31712448 |
| Enhancer experiment: | -- |
| Enhancer experiment description: | In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells |
About Target gene
| Target gene : | Axin2(AXIL,ODCRCS),Ccdc80 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells;In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells |
About TF
| TF name : | -- |
| TF experiment: | -- |
| TF experiment description: | In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells;In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells |
About Function
| Enhancer function : | In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
In contrast, the expression of Axin2 and Ccdc80 was strongly up-regulated in Wnt3a-treated HNF-1? mutant cells compared to wild-type cells |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene